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Abstract: Reduction in oxygen levels below normal concentrations plays important roles 
in different normal and pathological conditions, such as development, tumorigenesis, 
chronic kidney disease and stroke. Organisms exposed to hypoxia trigger changes at both 
cellular and systemic levels to recover oxygen homeostasis. Most of these processes are 
mediated by Hypoxia Inducible Factors, HIFs, a family of transcription factors that directly 
induce the expression of several hundred genes in mammalian cells. Although different 
aspects of HIF regulation are well known, it is still unclear by which precise mechanism 
HIFs activate transcription of their target genes. Concomitantly, hypoxia provokes a 
dramatic decrease of general transcription that seems to rely in part on epigenetic changes 
through a poorly understood mechanism. In this review we discuss the current knowledge 
on chromatin changes involved in HIF dependent gene activation, as well as on other 
epigenetic changes, not necessarily linked to HIF that take place under hypoxic conditions. 
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1. Introduction 
Metazoans organisms utilize molecular oxygen during cellular respiration to produce sufficient 
amounts of ATP, as continuous and proper oxygen supply is an absolute requirement for survival. In 
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response to hypoxia, defined as the reduction of oxygen levels below normal values, complex 
mechanisms are triggered to allow adaptation to this environmental condition. These adaptive 
responses comprise changes at the systemic, tissue and cellular levels that tend to reduce oxygen 
consumption, and improve oxygen supply. Cardinal adaptations to hypoxia include angiogenesis, 
erythropoiesis, a switch from oxidative to glycolytic metabolism, and a partial shut-down of major 
energy consuming cellular processes [1–3]. 
Remarkably, hypoxic conditions take place during normal physiological processes, being a 
necessary stimulus for embryonic development and stem cell maintenance [4–7]. During different 
human pathological conditions, hypoxia also plays a major role. The pathologies include cancer, 
stroke, myocardium infarction and chronic kidney disease being the most relevant ones [3,8–11]. 
The cellular response to hypoxia is largely dependent on changes in gene expression, which are 
mainly commanded by a unique family of transcription factors named HIFs, for Hypoxia Inducible 
Factors [12–13]. HIFs are heterodimeric transcription factors composed of a constitutively expressed 
HIF-1β subunit and one of three oxygen-sensitive alpha subunits (HIF-1α, HIF-2α or HIF-3α) [14–15]. 
Under normal oxygen levels (normoxia), HIF-α subunits are hydroxylated in two key prolyl residues 
by specific prolyl-hydroxylases named PHD1, PHD2 and PHD3 [16–18]. These enzymes utilize 
molecular oxygen and 2-oxoglutarate as co-substrates for the reaction [18]. Hydroxylated HIF-αs are 
recognized by the von Hippel-Lindau protein (VHL), the substrate recognition subunit of an E3 
ubiquitin ligase complex; HIF-αs are then ubiquitinated and degraded at the 26S proteasome [19–21]. 
Under hypoxia, when oxygen is limiting, PHD activity is reduced, HIF-α subunits escape 
hydroxylation and proteolysis, leading to heterodimerization with the β-subunit and induction of 
hundreds of target genes through the binding of specific DNA sequences termed HREs (for Hypoxia 
Response Elements) [14]. Whereas HIF target genes are upregulated under oxygen deprivation, 
general transcription in the cell is largely inhibited [22]. 
Eukaryotic DNA is complexed with different histone and non-histone proteins to form the 
chromatin [23–24]. Histones play an essential role in DNA compaction as well as in the regulation of 
all DNA-related processes, including transcription, replication and DNA repair. The structural and 
functional unit of the chromatin is the nucleosome, which consists of an octamer of two molecules of 
each of the histones H2A, H2B, H3 and H4, around which 147 base pairs of DNA are wrapped [23–24]. 
Nucleosomes are connected by linker DNA which is associated with linker histones, usually H1 and 
H5 [24]. Nucleosomes together with the linker DNA are progressively folded and compacted into 
structures of higher-order [25–27]. Highly compacted chromatin has an inhibitory effect on 
transcription, since it limits the accessibility of the transcriptional machinery to the DNA [26]. All 
nucleosomal histones have a globular domain that forms the nuclesome core, and an N-terminal tail 
that protrudes away from the DNA [23]. Histone tails are subjected to multiple posttranslational 
modifications, including acetylation, methylation, phosphorylation and ubiquitination [28–29]. These 
histone marks have effects on both chromatin compaction and recruitment of different proteins that 
regulate transcription [30–31]. 
Besides the posttranslational modifications of the histone tails, chromatin can also be modified by 
various ATP-dependent chromatin remodeling complexes, which change the accessibility of the 
transcription machinery to particular loci, by promoting nucleosome sliding, nucleosome exchange or 
DNA exposure [32–34]. 
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Alteration of the gene expression profile is a common cellular response to different types of stress. 
Changes in gene expression under stress are intimately associated with alterations in chromatin 
structure, mediated by histone modifying and chromatin remodeling complexes [35]. In this review we 
will discuss the chromatin alterations that take place under hypoxia and the mechanisms by which they 
regulate gene expression to restore homeostasis under this condition. 
2. Role of HIF Co-Factors in the Response to Hypoxia 
In order for transcription to take place, an initiation complex conformed by the RNA Polymerase II 
and general transcription factors must overcome the physical barrier posed by the chromatin. It has 
been demonstrated that HIF recruits co-activators that modify the chromatin structure thereby 
facilitating access of the transcriptional machinery to the DNA. These so called HIF co-activators 
include the histone acetyltransferases (HAT) p300 and CREB-binding protein (CBP) [36–40], some 
histone deacetylases (HDACs) [41–42] and the chromatin remodeling complex SWI/SNF [43]. 
2.1. Role of Histone Acetyltransferases and Histone Deacetylases in the Response to Hypoxia 
Histone acetylation, a process strongly associated with transcriptional activation, takes place on 
lysine residues localized in histone N-terminal tails [44]. Histone acetylation induces transcription by 
relaxing high-order structures of the chromatin. In addition, acetylated histones create signals for the 
binding of bromodomain-containing proteins, which frequently present intrinsic HAT activity or are 
members of chromatin remodeling complexes, thereby contributing to transcription induction [30,44–46]. 
p300 and CBP are two paralogues with strong HAT activity, highly conserved in most multicellular 
organisms [47]. In addition to promoting histone acetylation, p300 and CBP function as physical 
bridges between several transcription factors and basal transcription machinery elements, such as the 
TATA binding protein and TFIIB, enhancing transcriptional activation [47–49]. p300 and CBP have 
strong co-activator effect on HIF dependent transcriptional induction [36–40]. 
Both HIF-1α and HIF-2α have been shown to interact with p300/CBP through two distinct 
transactivation domains termed C-TAD [50–51] and N-TAD [52]. HIF C-TAD, placed next to the HIF 
carboxy-terminal end, interacts with a p300/CBP domain named CH1. The more centrally localized 
HIF N-TAD interacts with a different p300/CBP protein domain called CH3 [50–52]. 
Interaction between p300/CBP CH1 and HIF C-TAD is regulated by oxygen, mainly through the 
hydroxylation of a single asparagine residue within the HIF C-TAD [53]. This hydroxylation, 
catalyzed by a hydroxylase termed Factor Inhibiting HIF (FIH-1) [54–55], prevents the interaction 
between HIF-α and p300/CBP. Like Prolyl-4-hydroxylases (PHDs), FIH-1 also requires molecular 
oxygen for catalysis. Under hypoxia, when oxygen availability is limiting, asparagine hydroxylation is 
inhibited, and the interaction between HIF and p300/CBP is restored, thereby allowing HIF dependent 
transcription in hypoxia (Figure 1A, upper panel). Interaction between the CH3 domain of p300/CBP 
and HIF-1α N-TAD does not seem to be oxygen-sensitive and it is significantly weaker than the  
CH1-C-TAD interaction [52,56]. 
In addition to FIH-1 dependent regulation, several other factors and pathways have been shown to 
modulate the interaction between p300/CBP and HIF-α subunits. These additional regulatory factors 
include positive regulators, such as casein kinase II and mitogen-activated protein kinase (MAPK), as 
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well as negative regulators, including CITED2 andCITED4 [3,35,57]. Sirtuins are a family of 
nicotinamide adenine dinucleotide (NAD+)-dependent deacetylases that sense the redox state of the 
cell. Sirtuin1 (SIRT1) is an interesting modulator of HIF activity that negatively regulates HIF-1α [58] 
and positively regulates HIF-2α [59]. SIRT1 reduces HIF-1α activity by abrogating interaction 
between p300/CBP and HIF-1α [58]. Whether p300/CBP plays a role on SIRT1-mediated positive 
regulation of HIF-2α is unknown. Although p300/CBP have been shown to regulate expression of 
various HIF dependent reporters and several HIF target genes [36,40,60], as well as to display histone 
acetylation activity over a few HIF target promoters [43,61–62] (Table 1), a general requirement of 
these factors in HIF dependent transcription has not been demonstrated. Furthermore, work carried out 
by Kasper and colleagues [63] suggests instead, that the role of p300/CBP in the HIF-dependent 
cellular response to hypoxia may not be as general as predicted from studies carried out in vitro. These 
authors demonstrated that simultaneous deletion of the CH1 domain of both p300 and CBP provoked 
very diverse effects on the induction of 40 different HIF target genes. This implies that the requirement 
of this domain is gene-specific, being essential for some genes and dispensable for others. In 
agreement with this, a recent study has shown that individual knock down of p300 or CBP does not 
reduce hypoxic induction of the HIF target genes LDH-A and PGK, suggesting that p300 and CBP are 
either redundant or dispensable in the expression of these and possibly other HIF targets [62].  
Table 1. Gene-specific histone modifications induced under hypoxia. Histone 
modifications induced at promoter regions of hypoxia-responsive genes. Up and down 
arrows indicate hypoxia-dependent increase or decrease of each of the modifications. 
Events typically associated with transcriptional repression are highlighted in red and those 
associated with transcriptional activation are in green. Abbreviations: me1/2/3, mono-/di-/tri- 
methylation; ac, acetylation. 
Gene Event References 
Hypoxia-induced genes: 
VEGF A ↑ H3ac 
↑ H3K4me3 
↓ H3K27me3 
[22,61] 
EPO ↑ H3ac 
↑ H4ac 
[43,62] 
EGR1 ↑ H3ac 
↑ H3K4me3 
↓ H3K9/27me2 
↓ H3K27me3 
[22] 
ADM 
GDF15 ↑ H3K9me2 
[64] 
HMOX1 
DAF ↑ H3K4me3 
[65] 
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Table 1. Cont. 
Gene Event References 
Hypoxia-repressed genes: 
SP-A ↓ H3ac 
↑ H3K9me2 
[66] 
AFP 
Albumin 
↓ H3ac 
↑ H3K9/27me2 
[22] 
↑ H3K4me3 
↓ H3K27me3 
Mlh1 
Dhfr ↑ H3K9me2 
[67] 
Ccl2 
Ccr1 
Ccr5 
↑ H3K9me2 
↑ H3K9me3 
[68] 
Why does deletion of the CH1 domain of the two HATs provoke only a moderate effect on the 
expression of certain HIF target genes? In principle, one explanation could be that p300/CBP are 
recruited to specific promoters through their intact CH3 domains. Nevertheless, this is apparently not 
the case, since CH1 deletion severely reduces the recruitment of p300/CBP to HIF target promoters, 
without significantly affecting gene expression. Thus, it seems likely that p300/CBP are dispensable 
for HIF dependent induction of a subset of HIF target genes [63]. 
Histone acetylation is controlled by the opposing activities of HATs and HDACs [69]. In mammals 
18 different HDACs have been identified so far [70–73]. It is well known that HDAC substrates also 
include non-histone proteins, including several transcription factors and co-factors [74].  
By targeting histones or non-histone proteins, HDACs generally have a negative effect on 
transcription [74], but interestingly, they can regulate HIF dependent transcription both positively or 
negatively. It was shown that under hypoxia, a HIF target gene named RECK is downregulated through 
a mechanism that involves recruitment of HDAC1 to its promoter [75]. It was shown in addition, that 
in hypoxia the chromatin-remodeling factor Reptin binds simultaneously to HIF-1α and HDAC1, 
recruiting in this way a repressive complex containing HDAC1 to a subset of HIF target genes [76] 
(Figure 1B). On the other hand, recruitment of HDAC4, HDAC5 and HDAC7 to HIF target promoters 
since has a positive role in HIF dependent transcription [41–42]. Consistent with this, histone 
deacetylase inhibitors, that in most cases promote gene expression, in the context of several HIF target 
promoters provoke inhibition of transcription [63,77] and of HIF-dependent angiogenesis [74,78–80]. 
The mechanism involved in HDAC-dependent gene activation is not well defined as yet. However, it is 
becoming increasingly clear that for HIF C-TAD-p300/CBP interaction to take place, a deacetylation 
reaction is required [74]. Available evidence suggests that p300/CBP and not HIF are targets of such 
deacetylation [77]. In line with this notion, HIF, p300 and HDAC4, HDAC5 or HDAC7 have  
been reported to form a multiprotein complex [41–42]. It was also shown that HDAC4 and  
HDAC5 promote association between HIF-1α and p300, thereby enhancing expression of HIF target 
genes [42] (Figure 1A, upper panel). 
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Figure 1. Epigenetic regulation of transcription in response to hypoxia. Schematic 
representation of the different epigenetic mechanisms involved in the expression of 
different genes in response to hypoxia. (a) HIF recruits co-activators that enhance gene 
expression. Upper panel: p300/CBP histone acetyltransferases interact with HIF and 
acetylate histones in HIF target promoters. HIF-p300/CBP interaction is induced in 
hypoxia through FIH-1 inhibition. HDAC4, HDAC5 or HDAC7 form a multiprotein 
complex with HIF-p300 increasing HIF transcriptional activity. HDAC4 and HDAC5 exert 
their effects by promoting association between HIF and p300. Middle panel: The SWI/SNF 
complex alters the chromatin structure in some HIF target promoters or enhancers, thereby 
favoring their expression. Lower panel: Hypoxia promotes changes in the histone 
methylation status at promoters of hypoxia-inducible genes: Oxygen deprivation activates 
JMJD1A and inhibits JARID1A histones demethylases, which provoke respectively a 
decrease in H3K9me2 and an increase in H3K4me2 levels at their target promoters, thus 
enhancing gene expression. In addition, hypoxia increases H3K4me3 and H3K27me3 
levels in some HIF target promoters through an unknown mechanism; (b) Under hypoxia, 
the interaction between Reptin and HIF1-α is enhanced, leading to recruitment of HDAC1 
to some HIF target genes, negatively regulating their transcription; (c) The histone 
methylation and acetylation status changes in promoters of hypoxia-repressed genes. 
Hypoxia provokes an increase in H3K9me2 levels as a result of G9a up-regulation. 
Increased H3K4me3 levels and decreased H3K27me3 and H3K9ac levels have also been 
observed. Epigenetic events typically associated with transcriptional repression are 
highlighted in red and those usually associated with transcriptional activation are 
highlighted in green. Abbreviations: HDAC, Histone Deacetylase; H3, histone H3; me2/3, 
di/tri-methylated; ac, acetylated. 
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2.2. Role of Chromatin Remodeling in the Response to Hypoxia 
Relatively little is known about the role of chromatin-remodeling complexes in the transcriptional 
response to hypoxia. To date, there are only two studies covering this issue, and both have focused in a 
unique complex termed SWI/SNF [43,81]. 
SWI/SNF utilizes energy derived from ATP hydrolysis to disrupt interactions between DNA and 
histones thereby changing chromatin structure, generally facilitating the access of DNA-binding 
proteins to their target sequences [82]. 
It has been demonstrated that components of the SWI/SNF complex are recruited to the EPO 
enhancer (a HIF target), and that this recruitment is required for full EPO induction under hypoxia [43] 
(Figure 1A, middle panel). It was shown in addition, that in hypoxia the SWI/SNF complex is recruited 
to the promoter of the HIF-1α gene and that this is required for expression of HIF-1α mRNA. Thus, 
this study concluded that modulation of SWI/SNF levels can account for deep changes in  
HIF-dependent responses to hypoxia [81]. We have recently carried out a genome-wide RNAi screen 
in Drosophila cells aimed to detect novel HIF activators. Several components of the SWI/SNF 
complex (called Brahma complex in Drosophila) have emerged as hits of the screen, suggesting that 
the requirement of the SWI/SNF complex in the transcriptional response to hypoxia is a conserved 
feature in animal evolution [83]. 
3. Role of Jumonji-Domain Containing Histone Demethylases in the Response to Hypoxia 
Histones can be methylated in specific lysine (K) or arginine (R) residues, which can appear as 
mono-, di-, or tri-methylated forms. Methylated histone residues induce alterations in compaction of 
the chromatin, and also provide binding sites for different proteins that regulate gene expression, 
resulting in the inhibition or enhancement of transcription [84–87]. Although some exceptions have 
been reported [30,88], in general, methylation at lysines 4, 36 or 79 of H3 are hallmarks of chromatin 
active regions, whereas methylation of lysines 9 and 27 of H3, as well as of H4 lysine 20 are 
associated with transcriptional repression and heterochromatin formation [29,86]. Work carried out 
over the last ten years has shown that histone methylation is a tightly regulated process, dependent on 
the activity of both histone methyltransferases and histone demethylases (HDMs) [29,86].  
The Jumonji C (JmjC)-domain containing histone demethylases (JHDM) constitute the largest 
family of lysine demethylases. JHDM family members utilize molecular oxygen (O2), Fe(II) and  
2-oxoglutarate to remove methyl groups from specific histone residues through an hydroxylation 
reaction. Several lines of evidence have linked JHMD function to hypoxia [64,89–90]. 
As JHDMs utilize O2 as a co-substrate in the demethylation reaction, one could anticipate that their 
enzymatic activity is compromised under hypoxia. In agreement with this, it was demonstrated that the 
activity of over-expressed JMJD1A and JMJD2B was diminished, although not completely abrogated, 
when cells were exposed to 0.2% O2 [91]. Interestingly, most members of the JDHM family have been 
reported to be transcriptionally induced under hypoxic conditions [64,89,91–93]. It was therefore 
proposed that JHDM induction under hypoxia tends to restore histone methylation homeostasis, in 
such a way that when oxygen availability is limiting, by increasing the expression of these enzymes, 
reduction of enzymatic activity due to oxygen scarcity is totally or partially compensated [89]. In 
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agreement with this model, 17 out of the 22 JHDM family members are induced under hypoxic 
conditions [89], and at least 4 of them, JMJD1A, JMJD2B, JMJD2C and JARID1B, are HIF direct 
targets, as evidenced by chromatin immunoprecipitation (ChIP) assays [64,89,91–93]. 
Results reported by Xia et al. [89] support a role of a JHDM named JARID1B in histone 
methylation homeostasis: They have shown that under hypoxia, genome-wide levels of tri-methyl 
lysine 4 of histone H3 (H3K4me3) are increased, and that this increase is enhanced if cells are 
additionally depleted from HIF-β. As the effect on histone methylation elicited by the depletion of HIF 
can be over-came by JARID1B overexpression, it was proposed that JARID1B HIF-dependent 
induction is necessary to prevent H3K4 hypermethylation under hypoxia. Considering that some 
JHDMs, including JMJD1A and JMJD2B, are induced by hypoxia to a higher extent than other 
members of the family [89,91–92], and taking into account that JHDMs display residue specificity, 
hypermethylation of some histone lysines under hypoxia could be specially prevented.  
It has been proposed that in addition to a possible role of the JHDMs in global histone methylation 
homeostasis under hypoxia [89], some family members might play a direct role in specific gene 
expression [93]. In fact, Krieg and colleagues [64] have recently demonstrated that JMJD1A is 
necessary for full hypoxic induction of 53 genes, including several HIF targets such as ADM, EDN1, 
SERPINE1, PLAUR and HMOX1. Moreover, they have shown that JMJD1A contributes to  
hypoxia-dependent gene expression by demethylating H3K9me2 in certain hypoxia responsive 
promoters, such as ADM and GDF15 [64] (Figure 1A, lower panel). Notably, JMJD1A recruitment 
reduces, although it does not completely prevent, hypoxic induction of H3K9me2 on selected 
promoters [64]. 
It was reported that hypoxia induces global histone methylation possibly through partial inhibition 
of JHDMs [22,65,67], while it reduces histone methylation of certain hypoxia-responsive promoters [22]. 
Tausendschön et al. have shown that in macrophages, hypoxia provokes an increase in H3K9 di- and 
tri-methylation in promoter regions of several hypoxia-repressed genes, while hypoxia has no effect on 
these modifications in the promoter region of the hypoxia-inducible gene ADM [68].Gene-specific 
recruitment of JMJD1A (and probably other JHDMs) can explain this dual effect. It remains to be 
determined the molecular mechanisms that target JMJD1A to specific promoters.  
Interestingly, JMJD1A is a HIF target gene itself. Krieg and colleagues [64] suggested that 
regulation of JMJD1A by HIF may represent a feed-forward mechanism for favoring HIF-dependent 
gene expression. They proposed that JMJD1A maintains an active epigenetic pattern in target 
promoters, thereby minimizing the energy required to support expression. 
The specific regulation of just a subset but not all hypoxia-inducible genes by JMJD1A suggests 
that additional promoter-specific mechanisms account for differential gene induction. It is tempting to 
speculate that other JHDMs are also involved in the activation of specific hypoxia responsive genes. 
Further research is required to determine if this is indeed the case. 
Although progress has been made in characterizing JHDM induction under hypoxia, detailed studies 
on the biological roles of this family of enzymes in the response to hypoxia needs to be carried out. 
RNAi silencing experiments targeting individual or multiple JHDMs, and posterior analysis of global 
as well as promoter-specific histone methylation will help to clarify the role of these enzymes in 
hypoxia-dependent regulation of transcription. 
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4. Gene-Specific Histone Modifications Induced under Hypoxia 
Johnson et al. [22] analyzed hypoxia-induced epigenetic changes in the promoter regions of genes 
activated or repressed under oxygen deprivation. Hypoxic induction of the HIF target genes VEGF and 
EGR1 correlates with a marked increase in H3K9ac and H3K4me3 levels and a decrease in 
H3K27me3 levels in their promoters, three events usually associated with transcriptional active loci 
(Figure 1A, lower panel). The same or similar epigenetic changes have also been observed at the 
promoters of the hypoxia-inducible genes EPO, HMOX1 and DAF [43,62,65] (Table 1). Hypoxic 
induction of H3K4me3 seems to rely on the inhibition of the JARID1A demethylase [65]. 
In contrast, promoters of several hypoxia-repressed genes show decreased levels of H3K9ac [22,66] 
and/or increased levels of H3K9me2 [22,66–68] under hypoxia, events typically associated with 
transcriptional repression (Table 1). Available evidence suggests that H3K9me2 increase is supported 
in part by the hypoxic-dependent induction of the G9a methyltransferase [67] (Figure 1C). 
Of interest, hypoxia also increased H3K9me2 levels at the promoters of some genes induced in 
hypoxia [64] (Table 1), as well as it provokes modifications typically associated with transcriptional 
activation (increased H3K4me3 and decreased H3K27me3 levels) at the promoters of some hypoxia-
repressed genes [22] (Figure 1C and Table 1). These observations are not paradoxical, since patterns of 
histone modifications can be differentially interpreted by transcriptional factors and co-factors, 
depending on the epigenetic and cellular contexts [88]. Then, a so called “positive” histone mark can 
have repressive effects in particular physiologic situations, or vice versa, a typical “negative” 
modification can favor transcription in a certain physiologic context. Further research is required to 
assess the biological outcome of hypoxia-induced epigenetic changes.  
5. Global Histone Modifications Induced under Hypoxia 
In addition to promoter-specific chromatin alterations, cells exposed to hypoxia show global 
epigenetic changes [22,65–68,89,94–95]. Several groups have shown that the global acetylation and 
methylation profiles of H3 and H4 [22,67,94] and also methylation of the DNA (recently reviewed  
in [96]) are oxygen sensitive. Remarkably, among the hypoxia-induced global epigenetic alterations, 
histone posttranslational modifications usually associated to either transcriptional repression or 
activation have been reported [22,65–68,89,94–95] (Table 2). 
It has been shown that hypoxia provokes general reduction of gene transcription [22]. However, it 
remains to be determined to what extent global epigenetic alterations account for this global gene 
downregulation in situations of oxygen shortage. Johnson and colleagues [22] have determined that 
HePa 1–6 cells incubated in strong hypoxia (0.2% O2 for 48 h) reduce their overall rate of transcription 
to about 50% of their usual normoxic levels. This sharp reduction in mRNA synthesis correlates with 
several histone modifications, that are not only associated with transcriptional repression, but also with 
transcriptional induction. Again, as a particular histone mark can promote different, even opposite 
biological effects, it cannot be ruled out that these “positive” histone marks globally induced under 
oxygen deprivation might have negative effects in the particular physiological and epigenetic contexts 
that take place under this condition. 
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Table 2. Global histone modifications induced under hypoxia. Oxygen deprivation 
provokes global epigenetic changes usually associated with either transcriptional repression 
(red) or activation (green). Up and down arrows indicate that the corresponding 
modification is provoked or prevented by hypoxia. Abbreviations: me1/2/3, mono-/di-/tri- 
methylation; ac, acetylation. 
Histone Residue Modification Event References 
H3 K4 me1 ↑ [22] 
  me2 ↑ [22,89] 
  me3 ↑ [22,65,89] 
 K9 ac ↓ [22,26,66–67] 
  me1 ↓ [67,94] 
  me2 ↑ [22,66–68,89,94] 
  me3 ↑ [67–68,94] 
 K14 ac ↑ [22] 
 K27 me3 ↑ [22] 
 K36 me3 ↑ [68,89] 
 K79 me2 ↑ [22] 
H4 R3 me2 ↑ [22] 
 K5,8,12,16 ac ↓ [22,94] 
An increase in di- and tri-methylation of H3K9, two typically repressive marks, are among the best 
characterized global modifications induced under hypoxia [22,66–68,94,97] (Table 2). Chen et al. [67] 
have demonstrated that the hypoxia-dependent increase in H3K9me2 stems from both increased 
methylation and decreased demethylation of H3K9. These authors have shown that at 0.2% O2 the 
activity of the methyltransferase G9a increases, supporting in part the accumulation of methylated 
species. In addition, they have shown that demethylation of H3K9me2 is reduced under hypoxia, 
although the identity of the particular demethylases whose activity diminishes is unknown. As has 
been mentioned above, JDHM activity is partially inhibited at 0.2% O2, so one possibility is that 
reduction of H3K9me2 demethylation is a consequence of partial loss of activity of one or more JHDM.  
Remarkably, deacetylation of H3K9, another chromatin modification associated with transcriptional 
repression, globally increases under oxygen deprivation conditions [22,66–67,89,94]. Thus, taken 
together, these observations suggest that in hypoxia H3K9 acetyl groups are globally replaced by di- or 
tri- methyl groups establishing a mechanism that might account for the overall transcriptional 
repression seen in response to oxygen deprivation (Table 2). 
In hypoxia, global induction of H3K4 di- or tri- methylation, both of them modifications usually 
associated with transcriptional activation, have also been well documented [22,66–68,89,94] (Table 2). 
Experiments carried out by Zhou et al. [65] suggest that hypoxia provokes an increase in H3K4me3 by 
inhibiting JARID1A demethylase activity, rather than by inducing methylation. 
In summary, oxygen deprivation induces a widespread combination of histone modifications that 
are usually associated with either transcriptional repression or transcriptional activation. The field is 
now beginning to define more precisely these modifications, although more research is required to 
fully understand their biological roles, as well as to identify the enzymes and signaling pathways 
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involved. It will be highly relevant to assess the impact of preventing the global epigenetic changes 
that occur under hypoxia, over general transcriptional repression and specific gene induction. 
6. Concluding Remarks 
In order to activate gene transcription, HIF recruits a range of gene-specific co-factors that 
acetylate/ormethylate histones, or change chromatin structure. It would be very interesting to define 
the mechanisms that recruit co-factors to specific hypoxia-inducible genes. On the other hand, the 
hypoxic stimulus induces a general repression of transcription, presumably supported by global 
chromatin changes. Therefore, it seems that epigenetic mechanisms play a dual role in gene regulation 
under hypoxia, controlling HIF target gene induction and the downregulation of general transcription.  
Acknowledgments 
We thank Wappner lab members, especially Agostina Bertolin and Mariana Melani for useful 
comments on this manuscript. 
References 
1. Kaelin, W.G., Jr.; Ratcliffe, P.J. Oxygen sensing by metazoans: The central role of the HIF 
hydroxylase pathway. Mol. Cell 2008, 30, 393–402. 
2. Semenza, G.L., Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 
(Bethesda) 2009, 24, 97–106. 
3. Majmundar, A.J.; Wong, W.J.; Simon, M.C. Hypoxia-inducible factors and the response to 
hypoxic stress. Mol. Cell 2010, 40, 294–309. 
4. Stone, J.; Itin, A.; Alon, T.; Pe’er, J.; Gnessin, H.; Chan-Ling, T.; Keshet, E. Development of 
retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) 
expression by neuroglia. J. Neurosci. 1995, 15, 4738–4747. 
5. Chen, E.Y.; Fujinaga, M.; Giaccia, A.J. Hypoxic microenvironment within an embryo induces 
apoptosis and is essential for proper morphological development. Teratology 1999, 60, 215–225. 
6. Krishnan, J.; Ahuja, P.; Bodenmann, S.; Knapik, D.; Perriard, E.; Krek, W.; Perriard, J.C. 
Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac 
morphogenesis and function. Circ. Res. 2008, 103, 1139–1146. 
7. Dunwoodie, S.L. The role of hypoxia in development of the Mammalian embryo. Dev. Cell 2009, 
17, 755–773. 
8. Nangaku, M. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage 
renal failure. J. Am. Soc. Nephrol. 2006, 17, 17–25. 
9. Shi, H. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr. Med. Chem. 
2009, 16, 4593–4600. 
10. Lu, X.; Kang, Y. Hypoxia and hypoxia-inducible factors: Master regulators of metastasis. Clin. 
Cancer Res. 2010, 16, 5928–5935. 
11. Semenza, G.L. HIF-1: Upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 
2010, 20, 51–56. 
Int. J. Mol. Sci. 2011, 12            
 
 
4716 
12. Maxwell, P.H.; Pugh, C.W.; Ratcliffe, P.J. Inducible operation of the erythropoietin 3’ enhancer 
in multiple cell lines: Evidence for a widespread oxygen-sensing mechanism. Proc. Natl. Acad. 
Sci. USA 1993, 90, 2423–2427. 
13. Wang, G.L.; Semenza, G.L. General involvement of hypoxia-inducible factor 1 in transcriptional 
response to hypoxia. Proc. Natl. Acad. Sci. USA 1993, 90, 4304–4308. 
14. Semenza, G.L. HIF-1, O(2), and the 3 PHDs: How animal cells signal hypoxia to the nucleus. Cell 
2001, 107, 1–3. 
15. Bruick, R.K. Oxygen sensing in the hypoxic response pathway: Regulation of the hypoxia-inducible 
transcription factor. Genes. Dev. 2003, 17, 2614–2623. 
16. Bruick, R.K.; McKnight, S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. 
Science 2001, 294, 1337–1340. 
17. Epstein, A.C.; Gleadle, J.M.; McNeill, L.A.; Hewitson, K.S.; O'Rourke, J.; Mole, D.R.;  
Mukherji, M.; Metzen, E.; Wilson, M.I.; Dhanda, A.; et.al. C. elegans EGL-9 and mammalian 
homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 
107, 43–54. 
18. Schofield, C.J.; Ratcliffe, P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 
2004, 5, 343–354. 
19. Maxwell, P.H.; Wiesener, M.S.; Chang, G.W.; Clifford, S.C.; Vaux, E.C.; Cockman, M.E.; 
Wykoff, C.C.; Pugh, C.W.; Maher, E.R.; Ratcliffe, P.J. The tumour suppressor protein VHL 
targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399, 271–275. 
20. Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; Salic, A.; Asara, J.M.; Lane, 
W.S.; Kaelin, W.G., Jr. HIFalpha targeted for VHL-mediated destruction by proline 
hydroxylation: Implications for O2 sensing. Science 2001, 292, 464–468. 
21. Jaakkola, P.; Mole, D.R.; Tian, Y.M.; Wilson, M.I.; Gielbert, J.; Gaskell, S.J.; Kriegsheim, A.; 
Hebestreit, H.F.; Mukherji, M.; Schofield, C.J.; Maxwell, P.H.; Pugh, C.W.; Ratcliffe, P.J. 
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl 
hydroxylation. Science 2001, 292, 468–472. 
22. Johnson, A.B.; Denko, N.; Barton, M.C. Hypoxia induces a novel signature of chromatin 
modifications and global repression of transcription. Mutat. Res. 2008, 640, 174–179. 
23. Kornberg, R.D.; Lorch, Y. Twenty-five years of the nucleosome, fundamental particle of the 
eukaryote chromosome. Cell 1999, 98, 285–294. 
24. Hayes, J.J.; Hansen, J.C. Nucleosomes and the chromatin fiber. Curr. Opin. Genet. Dev. 2001, 11, 
124–129. 
25. Horn, P.J.; Peterson, C.L. Molecular biology. Chromatin higher order folding--wrapping up 
transcription. Science 2002, 297, 1824–1827. 
26. Nemeth, A.; Langst, G. Chromatin higher order structure: Opening up chromatin for transcription. 
Brief. Funct. Genomic Proteomic 2004, 2, 334–343. 
27. Tremethick, D.J. Higher-order structures of chromatin: The elusive 30 nm fiber. Cell 2007, 128, 
651–654. 
28. Luger, K.; Richmond, T.J. The histone tails of the nucleosome. Curr. Opin. Genet. Dev. 1998, 8, 
140–146. 
29. Jenuwein, T.; Allis, C.D. Translating the histone code. Science 2001, 293, 1074–1080. 
Int. J. Mol. Sci. 2011, 12            
 
 
4717 
30. Peterson, C.L.; Laniel, M.A. Histones and histone modifications. Curr. Biol. 2004, 14, R546–R551. 
31. Lee, J.S.; Smith, E.; Shilatifard, A. The language of histone crosstalk. Cell 2010, 142, 682–685. 
32. Eisen, J.A.; Sweder, K.S.; Hanawalt, P.C. Evolution of the SNF2 family of proteins: Subfamilies 
with distinct sequences and functions. Nucleic Acids Res. 1995, 23, 2715–2723. 
33. Muchardt, C.; Yaniv, M. ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the 
job. J. Mol. Biol. 1999, 293, 187–198. 
34. Havas, K.; Whitehouse, I.; Owen-Hughes, T. ATP-dependent chromatin remodeling activities. 
Cell. Mol. Life Sci. 2001, 58, 673–682. 
35. Johnson, A.B.; Barton, M.C. Hypoxia-induced and stress-specific changes in chromatin structure 
and function. Mutat. Res. 2007, 618, 149–162. 
36. Arany, Z.; Huang, L.E.; Eckner, R.; Bhattacharya, S.; Jiang, C.; Goldberg, M.A.; Bunn, H.F.; 
Livingston, D.M. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. 
Acad. Sci. USA 1996, 93, 12969–12973. 
37. Ema, M.; Hirota, K.; Mimura, J.; Abe, H.; Yodoi, J.; Sogawa, K.; Poellinger, L.; Fujii-Kuriyama, 
Y. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to 
hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 1999, 
18, 1905–1914. 
38. Carrero, P.; Okamoto, K.; Coumailleau, P.; O'Brien, S.; Tanaka, H.; Poellinger, L. Redox-
regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to 
hypoxia-inducible factor 1alpha. Mol. Cell Biol. 2000, 20, 402–415. 
39. Ruas, J.L.; Poellinger, L.; Pereira, T. Functional analysis of hypoxia-inducible factor-1 alpha-
mediated transactivation. Identification of amino acid residues critical for transcriptional 
activation and/or interaction with CREB-binding protein. J. Biol. Chem. 2002, 277, 38723–38730. 
40. Ruas, J.L.; Poellinger, L.; Pereira, T. Role of CBP in regulating HIF-1-mediated activation of 
transcription. J. Cell Sci. 2005, 118, 301–311. 
41. Kato, H.; Tamamizu-Kato, S.; Shibasaki, F. Histone deacetylase 7 associates with hypoxia-inducible 
factor 1alpha and increases transcriptional activity. J. Biol. Chem. 2004, 279, 41966–41974. 
42. Seo, H.W.; Kim, E.J.; Na, H.; Lee, M.O. Transcriptional activation of hypoxia-inducible  
factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1.  
FEBS Lett. 2009, 583, 55–60. 
43. Wang, F.; Zhang, R.; Beischlag, T.V.; Muchardt, C.; Yaniv, M.; Hankinson, O. Roles of Brahma 
and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J. Biol. Chem. 
2004, 279, 46733–46741. 
44. Peserico, A.; Simone, C. Physical and functional HAT/HDAC interplay regulates protein 
acetylation balance. J. Biomed. Biotechnol. 2011, 2011, 371832. 
45. Fischle, W.; Wang, Y.; Allis, C.D. Histone and chromatin cross-talk. Curr. Opin. Cell. Biol. 2003, 
15, 172–183. 
46. Shogren-Knaak, M.; Ishii, H.; Sun, J.M.; Pazin, M.J.; Davie, J.R.; Peterson, C.L. Histone H4-K16 
acetylation controls chromatin structure and protein interactions. Science 2006, 311,  
844–847. 
47. Kalkhoven, E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 2004, 68, 
1145–1155. 
Int. J. Mol. Sci. 2011, 12            
 
 
4718 
48. Bannister, A.J.; Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 1996, 
384, 641–643. 
49. Yuan, W.; Condorelli, G.; Caruso, M.; Felsani, A.; Giordano, A. Human p300 protein is a 
coactivator for the transcription factor MyoD. J. Biol. Chem. 1996, 271, 9009–9013. 
50. Dames, S.A.; Martinez-Yamout, M.; De Guzman, R.N.; Dyson, H.J.; Wright, P.E. Structural basis 
for Hif-1 alpha /CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. USA 
2002, 99, 5271–5276. 
51. Freedman, S.J.; Sun, Z.Y.; Poy, F.; Kung, A.L.; Livingston, D.M.; Wagner, G.; Eck, M.J. 
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. 
Acad. Sci. USA 2002, 99, 5367–5372. 
52. Ruas, J.L.; Berchner-Pfannschmidt, U.; Malik, S.; Gradin, K.; Fandrey, J.; Roeder, R.G.; Pereira, 
T.; Poellinger, L. Complex regulation of the transactivation function of hypoxia-inducible factor-1 
alpha by direct interaction with two distinct domains of the CREB-binding protein/p300. J. Biol. 
Chem. 2010, 285, 2601–2609. 
53. Lando, D.; Peet, D.J.; Whelan, D.A.; Gorman, J.J.; Whitelaw, M.L. Asparagine hydroxylation of 
the HIF transactivation domain a hypoxic switch. Science 2002, 295, 858–861. 
54. Mahon, P.C.; Hirota, K.; Semenza, G.L. FIH-1: A novel protein that interacts with HIF-1alpha 
and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001, 15, 2675–2686. 
55. Webb, J.D.; Coleman, M.L.; Pugh, C.W. Hypoxia, hypoxia-inducible factors (HIF), HIF 
hydroxylases and oxygen sensing. Cell. Mol. Life Sci. 2009, 66, 3539–3554. 
56. Pereira, T.; Zheng, X.; Ruas, J.L.; Tanimoto, K.; Poellinger, L. Identification of residues critical 
for regulation of protein stability and the transactivation function of the hypoxia-inducible  
factor-1alpha by the von Hippel-Lindau tumor suppressor gene product. J. Biol. Chem. 2003, 278,  
6816–6823. 
57. Lisy, K.; Peet, D.J. Turn me on: Regulating HIF transcriptional activity. Cell Death Differ. 2008, 
15, 642–649. 
58. Lim, J.H.; Lee, Y.M.; Chun, Y.S.; Chen, J.; Kim, J.E.; Park, J.W. Sirtuin 1 modulates cellular 
responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 2010, 38,  
864–878. 
59. Dioum, E.M.; Chen, R.; Alexander, M.S.; Zhang, Q.; Hogg, R.T.; Gerard, R.D.; Garcia, J.A. 
Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase 
sirtuin 1. Science 2009, 324, 1289–1293. 
60. Ebert, B.L.; Bunn, H.F. Regulation of transcription by hypoxia requires a multiprotein complex 
that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding 
protein. Mol. Cell. Biol. 1998, 18, 4089–4096. 
61. Jung, J.E.; Lee, H.G.; Cho, I.H.; Chung, D.H.; Yoon, S.H.; Yang, Y.M.; Lee, J.W.; Choi, S.; Park, 
J.W.; Ye, S.K.; Chung, M.H. STAT3 is a potential modulator of HIF-1-mediated VEGF 
expression in human renal carcinoma cells. FASEB J. 2005, 19, 1296–1298. 
62. Wang, F.; Zhang, R.; Wu, X.; Hankinson, O. Roles of coactivators in hypoxic induction of the 
erythropoietin gene. PLoS One 2010, 5, e10002. 
Int. J. Mol. Sci. 2011, 12            
 
 
4719 
63. Kasper, L.H.; Boussouar, F.; Boyd, K.; Xu, W.; Biesen, M.; Rehg, J.; Baudino, T.A.; Cleveland, 
J.L.; Brindle, P.K. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive 
gene expression. EMBO J. 2005, 24, 3846–3858. 
64. Krieg, A.J.; Rankin, E.B.; Chan, D.; Razorenova, O.; Fernandez, S.; Giaccia, A.J. Regulation of 
the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene 
expression and tumor growth. Mol. Cell. Biol. 2010, 30, 344–353. 
65. Zhou, X.; Sun, H.; Chen, H.; Zavadil, J.; Kluz, T.; Arita, A.; Costa, M. Hypoxia induces 
trimethylated H3 lysine 4 by inhibition of JARID1A demethylase. Cancer Res. 2010, 70,  
4214–4221. 
66. Islam, K.N.; Mendelson, C.R. Permissive effects of oxygen on cyclic AMP and interleukin-1 
stimulation of surfactant protein A gene expression are mediated by epigenetic mechanisms. Mol. 
Cell. Biol. 2006, 26, 2901–2912. 
67. Chen, H.; Yan, Y.; Davidson, T.L.; Shinkai, Y.; Costa, M. Hypoxic stress induces dimethylated 
histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res. 
2006, 66, 9009–9016. 
68. Tausendschon, M.; Dehne, N.; Brune, B. Hypoxia causes epigenetic gene regulation in 
macrophages by attenuating Jumonji histone demethylase activity. Cytokine 2011, 53, 256–262. 
69. Yang, X.J.; Seto, E. Collaborative spirit of histone deacetylases in regulating chromatin structure 
and gene expression. Curr. Opin. Genet. Dev. 2003, 13, 143–153. 
70. Ahringer, J. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 2000, 
16, 351–356. 
71. Blander, G.; Guarente, L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004, 73, 
417–435. 
72. Yang, X.J.; Gregoire, S. Class II histone deacetylases: From sequence to function, regulation, and 
clinical implication. Mol. Cell. Biol. 2005, 25, 2873–2884. 
73. Vaquero, A.; Sternglanz, R.; Reinberg, D. NAD+-dependent deacetylation of H4 lysine 16 by 
class III HDACs. Oncogene 2007, 26, 5505–5520. 
74. Chen, S.; Sang, N. Histone deacetylase inhibitors: The epigenetic therapeutics that repress 
hypoxia-inducible factors. J. Biomed. Biotechnol. 2011, 2011, 197946. 
75. Lee, K.J.; Lee, K.Y.; Lee, Y.M. Downregulation of a tumor suppressor RECK by hypoxia through 
recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. Biochim. Biophys. 
Acta 2010, 1803, 608–616. 
76. Lee, J.S.; Kim, Y.; Kim, I.S.; Kim, B.; Choi, H.J.; Lee, J.M.; Shin, H.J.; Kim, J.H.; Kim, J.Y.; 
Seo, S.B.; et al. Negative regulation of hypoxic responses via induced Reptin methylation. Mol. 
Cell 2010, 39, 71–85. 
77. Fath, D.M.; Kong, X.; Liang, D.; Lin, Z.; Chou, A.; Jiang, Y.; Fang, J.; Caro, J.; Sang, N. Histone 
deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors 
independently of direct acetylation of HIF-alpha. J. Biol. Chem. 2006, 281, 13612–13619. 
78. Marks, P.A.; Richon, V.M.; Breslow, R.; Rifkind, R.A. Histone deacetylase inhibitors as new 
cancer drugs. Curr. Opin. Oncol. 2001, 13, 477–483. 
79. Johnstone, R.W.; Licht, J.D. Histone deacetylase inhibitors in cancer therapy: Is transcription the 
primary target? Cancer Cell 2003, 4, 13–18. 
Int. J. Mol. Sci. 2011, 12            
 
 
4720 
80. Drummond, D.C.; Noble, C.O.; Kirpotin, D.B.; Guo, Z.; Scott, G.K.; Benz, C.C. Clinical 
development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. 
Toxicol. 2005, 45, 495–528. 
81. Kenneth, N.S.; Mudie, S.; van Uden, P.; Rocha, S. SWI/SNF regulates the cellular response to 
hypoxia. J. Biol. Chem. 2009, 284, 4123–4131. 
82. Tang, L.; Nogales, E.; Ciferri, C., Structure and function of SWI/SNF chromatin remodeling 
complexes and mechanistic implications for transcription. Prog. Biophys. Mol. Biol. 2010, 102, 
122–128. 
83. Dekanty, A.; Romero, N.M.; Bertolin, A.P.; Thomas, M.G.; Leishman, C.C.; Perez-Perri, J.I.; 
Boccaccio, G.L.; Wappner, P. Drosophila genome-wide RNAi screen identifies multiple 
regulators of HIF-dependent transcription in hypoxia. PLoS Genet. 2010, 6, e1000994. 
84. Klose, R.J.; Kallin, E.M.; Zhang, Y. JmjC-domain-containing proteins and histone demethylation. 
Nat. Rev. Genet. 2006, 7, 715–727. 
85. Shi, Y. Histone lysine demethylases: Emerging roles in development, physiology and disease. 
Nat. Rev. Genet. 2007, 8, 829–833. 
86. Shi, Y.; Whetstine, J.R. Dynamic regulation of histone lysine methylation by demethylases.  
Mol. Cell 2007, 25, 1–14. 
87. Loenarz, C.; Schofield, C.J. Expanding chemical biology of 2-oxoglutarate oxygenases.  
Nat. Chem. Biol. 2008, 4, 152–156. 
88. Berger, S.L., The complex language of chromatin regulation during transcription. Nature 2007, 
447, 407–412. 
89. Xia, X.; Lemieux, M.E.; Li, W.; Carroll, J.S.; Brown, M.; Liu, X.S.; Kung, A.L. Integrative 
analysis of HIF binding and transactivation reveals its role in maintaining histone methylation 
homeostasis. Proc. Natl. Acad. Sci. USA 2009, 106, 4260–4265. 
90. Yang, J.; Ledaki, I.; Turley, H.; Gatter, K.C.; Montero, J.C.; Li, J.L.; Harris, A.L. Role of 
hypoxia-inducible factors in epigenetic regulation via histone demethylases. Ann. N. Y. Acad. Sci. 
2009, 1177, 185–197. 
91. Beyer, S.; Kristensen, M.M.; Jensen, K.S.; Johansen, J.V.; Staller, P. The histone demethylases 
JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem. 
2008, 283, 36542–36552. 
92. Pollard, P.J.; Loenarz, C.; Mole, D.R.; McDonough, M.A.; Gleadle, J.M.; Schofield, C.J.; 
Ratcliffe, P.J. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-
inducible factor (HIF)-1alpha. Biochem. J. 2008, 416, 387–394. 
93. Wellmann, S.; Bettkober, M.; Zelmer, A.; Seeger, K.; Faigle, M.; Eltzschig, H.K.; Buhrer, C. 
Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem. Biophys. Res. 
Commun. 2008, 372, 892–897. 
94. Costa, M.; Davidson, T.L.; Chen, H.; Ke, Q.; Zhang, P.; Yan, Y.; Huang, C.; Kluz, T. Nickel 
carcinogenesis: Epigenetics and hypoxia signaling. Mutat. Res. 2005, 592, 79–88. 
95. Watson, J.A.; Watson, C.J.; McCrohan, A.M.; Woodfine, K.; Tosetto, M.; McDaid, J.; Gallagher, 
E.; Betts, D.; Baugh, J.; O'Sullivan, J.; Murrell, A.; Watson, R.W.; McCann, A. Generation of an 
epigenetic signature by chronic hypoxia in prostate cells. Hum. Mol. Genet. 2009, 18, 3594–3604. 
Int. J. Mol. Sci. 2011, 12            
 
 
4721 
96. Watson, J.A.; Watson, C.J.; McCann, A.; Baugh, J. Epigenetics the epicenter of the hypoxic 
response. Epigenetics 2010, 5, 293–296. 
97. Xia, X.; Kung, A.L. Preferential binding of HIF-1 to transcriptionally active loci determines  
cell-type specific response to hypoxia. Genome Biol 2009, 10, doi: 10.1186/gb-2009-10-10-r113. 
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
